Jerry Seinfeld city New York Scotland recommendations stars love Actor Citi Career audience Jerry Seinfeld city New York Scotland

Seinfeld star Hiram Kasten dies at 71 after battling prostate cancer and Crohn's disease

Reading now: 450
www.dailyrecord.co.uk

Actor Hiram Kasten, best known for his stint on Seinfeld, has passed away at the age of 71. His passing was announced on his official Facebook page on Sunday.

His obituary, which described him as "a truly charming guy," confirmed that he died earlier that day after a seven-year battle with various illnesses, including prostate cancer and Crohn's disease, which he had dealt with all his life, The Mirror reports.The much-loved comedian and actor had shared news of his terminal illness with close friends and family in the last six months.

He received an overwhelming amount of love and support, with frequent Zoom calls from friends, which his wife Diana believes "prolonged his life for at least another two months to be able to laugh with his peers."Throughout his life, Hiram became an iconic figure in the New York City comedy circuit, launching his stand-up career in 1978 after Jerry Seinfeld recommended him following an audition at The Comic Strip.

He quickly became a fixture in the comedy world, delighting audiences throughout the '70s and '80s.In addition to his stand-up, Hiram was also a talented actor, cherished for his role on the hit sitcom Seinfeld.

Read more on dailyrecord.co.uk
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Susan Hopkins - COVID-19 variants identified in the UK – latest updates - gov.uk - Britain - city Oxford
gov.uk
88%
102
COVID-19 variants identified in the UK – latest updates
UKHSA) has published its containing updated analysis of the emergent variant BA.2.86.BA.2.86 continues to transmit within the UK, with sporadic cases identified in most regions.The briefing contains early laboratory data from a number of scientific organisations around the UK, including UKHSA’s own Vaccine Development and Evaluation Centre (VDEC), the University of Oxford, the Glasgow Centre of Virus Research and the Pirbright Institute.This early data indicates that BA.2.86 is no more likely to evade existing antibodies than XBB.1.5, another variant that has been circulating widely in the UK.While the available data remains limited, there is currently no evidence to suggest that BA.2.86 infection is more likely to make people seriously ill than currently-circulating variants, while vaccination is likely to provide continued protection.UKHSA will continue to monitor vaccine effectiveness in the population throughout the winter and will publish updated analysis in due course.Professor Susan Hopkins, Chief Medical Advisor, UKHSA said:While this is still very early data and more research is needed before we can be certain, it is encouraging to see an initial indication that BA.2.86 demonstrates similar levels of antibody escape compared to other variants circulating in the UK. The available data is too limited to draw conclusions about the severity of the illness it causes, but there is so far no evidence to suggest that it is more likely to make people seriously ill than other Omicron variants in circulation.The autumn vaccination programme started this month, and this new data shows once again how important it is that the most vulnerable among us are fully vaccinated in order to receive the greatest possible protection.
DMCA